Table 2.
Variable | Model 1 | Model 2 | Model 3 | ||||||
---|---|---|---|---|---|---|---|---|---|
Beta ± SE | P † | P FDR ‡ | Beta ± SE | P † | P FDR ‡ | Beta ± SE | P † | P FDR ‡ | |
Overall (n = 932) | |||||||||
HOMA‐IR | −0.271 ± 0.078 | <0.001 | 0.003 | −0.259 ± 0.079 | 0.001 | 0.006 | −0.250 ± 0.082 | 0.002 | 0.012 |
HOMA‐IS | 0.036 ± 0.009 | <0.001 | 0.003 | 0.031 ± 0.009 | 0.002 | 0.006 | 0.028 ± 0.007 | 0.004 | 0.012 |
HOMA‐βF | −103.72 ± 62.1 | 0.096 | 0.144 | −104.71 ± 64.9 | 0.107 | 0.130 | −111.35 ± 68.7 | 0.106 | 0.127 |
OGTT‐0 h glucose | −0.060 ± 0.023 | 0.012 | 0.024 | −0.056 ± 0.025 | 0.023 | 0.046 | −0.067 ± 0.025 | 0.009 | 0.018 |
OGTT‐1 h glucose | −0.103 ± 0.097 | 0.291 | 0.291 | −0.051 ± 0.100 | 0.609 | 0.609 | −0.075 ± 0.103 | 0.466 | 0.467 |
OGTT‐2 h glucose | 0.106 ± 0.075 | 0.156 | 0.187 | 0.135 ± 0.076 | 0.108 | 0.130 | 0.126 ± 0.077 | 0.080 | 0.120 |
Statistical analysis | |||||||||
High dietary n‐3 PUFA (n = 466) | |||||||||
HOMA‐IR | −0.257 ± 0.100 | 0.011 | 0.022 | −0.214 ± 0.102 | 0.037 | 0.074 | −0.208 ± 0.104 | 0.045 | 0.090 |
HOMA‐IS | 0.042 ± 0.013 | 0.001 | 0.006 | 0.039 ± 0.013 | 0.004 | 0.024 | 0.038 ± 0.013 | 0.005 | 0.015 |
HOMA‐βF | −201.28 ± 121.82 | 0.999 | 0.999 | −203.7 ± 124.4 | 0.102 | 0.153 | −198.9 ± 128.3 | 0.122 | 0.183 |
OGTT‐0 h glucose | −0.095 ± 0.032 | 0.003 | 0.009 | −0.086 ± 0.033 | 0.008 | 0.024 | −0.092 ± 0.033 | 0.005 | 0.015 |
OGTT‐1 h glucose | −0.117 ± 0.139 | 0.958 | 0.999 | −0.007 ± 0.139 | 0.958 | 0.958 | −0.042 ± 0.141 | 0.768 | 0.768 |
OGTT‐2 h glucose | 0.059 ± 0.105 | 0.571 | 0.867 | 0.078 ± 0.106 | 0.461 | 0.553 | 0.042 ± 0.106 | 0.693 | 0.768 |
Low dietary n‐3 PUFA (n = 466) | |||||||||
HOMA‐IR | −0.042 ± 0.062 | 0.504 | 0.605 | −0.127 ± 0.193 | 0.511 | 0.767 | −0.129 ± 0.209 | 0.533 | 0.780 |
HOMA‐IS | 0.060 ± 0.438 | 0.169 | 0.338 | 0.018 ± 0.015 | 0.222 | 0.580 | 0.014 ± 0.015 | 0.360 | 0.720 |
HOMA‐βF | 0.020 ± 0.015 | 0.169 | 0.338 | 19.09 ± 55.62 | 0.732 | 0.878 | 20.73 ± 61.15 | 0.735 | 0.882 |
OGTT‐0 h glucose | −0.037 ± 0.036 | 0.297 | 0.446 | −0.039 ± 0.037 | 0.290 | 0.580 | −0.058 ± 0.039 | 0.145 | 0.435 |
OGTT‐1 h glucose | −0.061 ± 0.144 | 0.670 | 0.670 | −0.017 ± 0.147 | 0.908 | 0.908 | −0.005 ± 0.153 | 0.975 | 0.975 |
OGTT‐2 h glucose | 0.225 ± 0.109 | 0.040 | 0.240 | 0.249 ± 0.111 | 0.025 | 0.150 | 0.300 ± 0.115 | 0.009 | 0.054 |
Model 1 was adjusted for survey years, age, gestational age, pre‐pregnancy body mass index. Model 2 was further adjusted for gestational diabetes mellitus in a previous pregnancy, family history of diabetes, physical activities, smoking during pregnancy, alcohol consumption during pregnancy, dietary energy intake and dietary n‐3 polyunsaturated fatty acids (PUFAs) intake. Model 3 was further adjusted for occupation, monthly household income and educational level.
HOMA‐βF, homeostatic model assessment of β‐cell function; HOMA‐IR, homeostatic model assessment of insulin resistance; HOMA‐IS, homeostatic model assessment of insulin sensitivity; OGTT, oral glucose tolerance test; PUFA, polyunsaturated fatty acid; SE, standard error.
P‐value for multiple linear regression.
Corrected P‐value for false discovery rate (FDR).